Vision 1 Year after Gene Therapy for Leber’s Congenital Amaurosis

Схожие документы

• Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
  по: Cideciyan, Artur V., et al.
  Опубликовано: (2009)
• Defining the Residual Vision in Leber Congenital Amaurosis Caused by RPE65 Mutations
  по: Jacobson, Samuel G., et al.
  Опубликовано: (2008)
• Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
  по: Hauswirth, William W., et al.
  Опубликовано: (2008)
• Leber Congenital Amaurosis (LCA): Potential for Improvement of Vision
  по: Cideciyan, Artur V., et al.
  Опубликовано: (2019)
• Photoreceptor Layer Topography in Children with Leber Congenital Amaurosis Caused by RPE65 Mutations
  по: Jacobson, Samuel G., et al.
  Опубликовано: (2008)